Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Mar 1;64(5):656-663.
doi: 10.1093/cid/ciw863.

An Evidence-Based Algorithm for Early Prognosis of Severe Dengue in the Outpatient Setting

Affiliations
Multicenter Study

An Evidence-Based Algorithm for Early Prognosis of Severe Dengue in the Outpatient Setting

Minh Tuan Nguyen et al. Clin Infect Dis. .

Abstract

Background: Early prediction of severe dengue could significantly assist patient triage and case management.

Methods: We prospectively investigated 7563 children with ≤3 days of fever recruited in the outpatient departments of 6 hospitals in southern Vietnam between 2010 and 2013. The primary endpoint of interest was severe dengue (2009 World Health Organization Guidelines), and predefined risk variables were collected at the time of enrollment to enable prognostic model development.

Results: The analysis population comprised 7544 patients, of whom 2060 (27.3%) had laboratory-confirmed dengue; nested among these were 117 (1.5%) severe cases. In the multivariate logistic model, a history of vomiting, lower platelet count, elevated aspartate aminotransferase (AST) level, positivity in the nonstructural protein 1 (NS1) rapid test, and viremia magnitude were all independently associated with severe dengue. The final prognostic model (Early Severe Dengue Identifier [ESDI]) included history of vomiting, platelet count, AST level. and NS1 rapid test status.

Conclusions: The ESDI had acceptable performance features (area under the curve = 0.95, sensitivity 87% (95% confidence interval [CI], 80%-92%), specificity 88% (95% CI, 87%-89%), positive predictive value 10% (95% CI, 9%-12%), and negative predictive value of 99% (95% CI, 98%-100%) in the population of all 7563 enrolled children. A score chart, for routine clinical use, was derived from the prognostic model and could improve triage and management of children presenting with fever in dengue-endemic areas.

Keywords: dengue; diagnosis; tropical infectious diseases..

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Study profile with a description of the patient cohort and subgroups that were used to derive the prognostic models. Abbreviations: ELISA, enzyme-linked immunosorbent assay; IgM, immunoglobulin G; NS1, nonstructural protein 1; RT-PCR, reverse-transcription polymerase chain reaction.
Figure 2.
Figure 2.
Performance of the Early Severe Dengue Identifier (ESDI) in reverse-transcription polymerase chain reaction–positive dengue patients. A, Possible sensitivity/specificity trade-offs for different cutoff values of the ESDI and the distance from the corresponding points on the receiver operating characteristic (ROC) curve to the upper left corner (perfect model). B, ROC curve. C, Calibration plot displaying a scatterplot-smoother of predicted vs observed risks (dashed line), predicted vs observed risks for 10 patient strata of equal size grouped according to predicted risks (triangles), and the ideal identity line (solid line). The rugs at the bottom of the graphs characterize the distribution of predicted risks in severe dengue and nonsevere dengue cases, respectively. Abbreviation: AUC, area under the curve.
Figure 3.
Figure 3.
Nomogram of the prognostic model to predict the risk of severe dengue. A vertical line from a predictor value to the “points” axis assigns points to the 4 required variables: vomiting, platelet count (PLT), nonstructural protein 1 (NS1) rapid test status, and aspartate aminotransferase (AST) level. The sum of these points (total points) can then be translated to the corresponding predicted risk of severe dengue.

Comment in

  • Prognosticating Dengue.
    Low JG, Ooi EE. Low JG, et al. Clin Infect Dis. 2017 Mar 1;64(5):664-665. doi: 10.1093/cid/ciw867. Clin Infect Dis. 2017. PMID: 28034884 No abstract available.

References

    1. World Health Organization. Dengue: guideline for diagnosis, treatment, prevention and control. Geneva, Switzerland: WHO, 2009. - PubMed
    1. L’Azou M, Moureau A, Sarti E, et al. ; CYD14 Primary Study Group; CYD15 Primary Study Group Symptomatic dengue in children in 10 Asian and Latin American countries. N Engl J Med 2016; 374:1155–66. - PubMed
    1. Martinez-Torres E, Polanco-Anaya AC, Pleites-Sandoval EB. Why and how children with dengue die? Rev Cubana Med Trop 2008; 60:40–7.
    1. Ranjit S, Kissoon N. Dengue hemorrhagic fever and shock syndromes. Pediatr Crit Care Med 2011; 12:90–100. - PubMed
    1. Nguyen NM, Tran CN, Phung LK, et al. A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis 2013; 207:1442–50. - PMC - PubMed

Publication types

MeSH terms